申请人:SmithKline Beecham p.l.c.
公开号:US20040225006A1
公开(公告)日:2004-11-11
Compounds of formula (I) wherein R is hydrogen, alkyl, alkenyl, alkynyl, aryl, heteroaryl or heterocyclyl; and R
1
is bicyclyl or heterobicyclyl; are useful in the treatment and prophylaxis of conditions mediated by s-CD23 or TNF.
1
式(I)的化合物中,其中R为氢、烷基、烯基、炔基、芳基、杂芳基或杂环基;而R1为双环烷基或杂双环烷基;可用于治疗和预防由s-CD23或TNF.1介导的疾病。